August 22, 2014 12:27 PM ET

Biotechnology

Company Overview of Trine Pharmaceuticals, Inc.

Company Overview

As of March 31, 2008, Trine Pharmaceuticals, Inc. went out of business. Trine Pharmaceuticals Inc. is a biopharmaceutical company that develops and markets pharmaceutical products for gastrointestinal and metabolic diseases. The company also conducts pre-clinical and clinical testing of wound-healing compounds and focuses on antibiotic and antifungal resistance. It Cephalosporin program, in collaboration with Johnson & Johnson, targets serious gram-positive multidrug resistant infections. In addition, the company's Efflux Pump Inhibitor Program, targets gram-negative infections. It was formerly known as Essential Therapeutics Inc. and changed its name to Trine Pharmaceuticals, Inc. to Septem...

78 Fourth Avenue

Waltham, MA 02451

United States

Founded in 1992

Phone:

781-647-5554

Fax:

781-647-5552

Key Executives for Trine Pharmaceuticals, Inc.

Trine Pharmaceuticals, Inc. does not have any Key Executives recorded.

Similar Private Companies By Industry

Company Name Region
Vascular Magnetics, Inc. United States
FTA Bioscience, LLC United States
KREATECH Biotechnology USA Inc. United States
Sanammad Foundation United States
Beeologics, LLC United States

Recent Private Companies Transactions

Type
Date
Target
No transactions available in the past 12 months.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

Most Searched Private Companies

Company Name Geographic Region
NYC2012, Inc. United States
Lawyers Committee for Civil Rights Under Law United States
Bertelsmann AG Europe
Rush University United States
Greater Houston Partnership United States

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Trine Pharmaceuticals, Inc., please visit --. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.